Home›People›Mats Wahlstrom
MW

Mats Wahlstrom

Director at Coherus Oncology. Also a director at Circuit Clinical Solutions.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Jun 9, 2026·Suggest an edit

About Mats Wahlstrom

Mats Wahlstrom is a director at Coherus Oncology.

Form D filings name Mats Wahlstrom as a director at Circuit Clinical Solutions.

Mats Wahlstrom reports to the SEC as a director or major shareholder of 3 public companies, including TriSalus Life Sciences (TLSI) and Health Grades (HGRD).

Mats Wahlstrom first appears on SEC filings in 2009.

Experience

This experience comes from SEC filings. The years are when the filings name Mats Wahlstrom in the role, so the role may have started earlier or lasted longer.

Coherus Oncology, Inc.
Director
2014 – 2026 · Public company (CHRS)
TriSalus Life Sciences, Inc.
Director and 10% owner
2023 – 2026 · Public company (TLSI)
Circuit Clinical Solutions Inc.
Director
2016 – 2024 · Buffalo, NY
Health Grades Inc.
Director
2009 – 2010 · Public company (HGRD)

Key Colleagues at Startups

The people Mats Wahlstrom works with at each company, as listed on that company's latest Form D.

Circuit Clinical Solutions Inc. · Form D, Apr 17, 2024
LW
Laura Warwick
Executive officer
MS
Margaret Scott
Executive officer
TQ
Thomas Quinn
Director
WM
William Maggio
Executive officer
SO
Suzanne Oltz
Executive officer
JK
Jackie Kent
Director
CL
Craig Lipset
Director
BB
Brian Bocketti
Executive officer
IK
Irfan Khan
Executive officer and director
KH
Kerry Hicks
Director

Sources

  1. SECCircuit Clinical Solutions Inc. Form D, filed Apr 17, 2024
  2. SECForms 3, 4 and 5 filed by Mats Wahlstrom (SEC filer 1459154)